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The lack of physical mapping data strongly restricts the 
analysis of the meningioma chromosomal region that was 
assigned to the hands 22q12.3-qter. Recently, we reported 
a new marker D22S16 for chromosome 22 that was as- 
signed to the region 22q13-qter by in situ hybridization. 
Utilizing somatic cell hybrids we now sublocalized the 
marker D22Slf3 within the band region 22q12-13.1, thus 
placing it in the vicinity of the gene for the platelet derived 
growth factor (PDGFB). A physical map was established 
for the regions surrounding the PDGFB gene and the 
D22Sl6 marker. By means of pulsed-field gel electrophore- 
sis (PFGE) D22S16 and PDGFB were found to be physi- 
cally linked within 900 kb. We also identified two CpG 
clusters bordering the PDGFB gene. For the enzyme NotI, 
a variation of the PDGFB restriction pattern was found 
between different individuals. PFGE analysis of the two 
loci (PDFGB and D22S16) failed to identify major rear- 
rangements in meningioma. 0 1991 Academic Prees, Inc. 
INTRODUCTION 
Chromosome 22 contains only 1.9% of the total hap- 
loid human genome -57,000 kb (Rouleau et al., 1989). 
Despite its small size, chromosome 22 is involved in 
numerous inherited and acquired diseases (for review, 
see Kaplan et aZ., 1987). Accordingly, a physical map 
of chromosome 22 will contribute to the analysis of 
disorder-related rearrangements (e.g., in menin- 
gioma). By means of restriction fragment length poly- 
morphisms (RFLPs), genetic mapping has provided 
the gene location for hereditary disorders such as 
Huntington’s disease and cystic fibrosis (Gusella et 
al., 1983; White et al., 1985). However, genetic map- 
ping requires polymorphic probes and informative 
disease pedigrees. 
’ To whom reprint requests should be addressed at University of 
Michigan Medical Center, Department of Radiation Oncology, Di- 
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For meningiomas only a few kindreds have been 
described and map resolution is limited by availability 
of useful RFLP probes. Even until most recently, 
available RFLP probes have been only adequate to 
assign the candidate recessive oncogene to a relatively 
large 20-CM region between 22q12.3 and qter (Du- 
manski et al., 1987; Meese et al., 1987; Dumanski et 
al., 1990). 
The technique of pulsed-field gel electrophoresis 
(PFGE) (Carle and Olson, 1984; Schwartz and Can- 
tor, 1984) offers a powerful approach to generate pre- 
cise mapping information that does not depend upon 
recombination frequency. This is especially impor- 
tant for chromosome 22 where the genetic map (97 
CM) exceeds the calculated physical length (60 CM) by 
more than 60%, indicating a high recombination fre- 
quency (Rouleau et al, 1989). Using PFGE, only a 
limited number of probes (e.g., 100 adjacent frag- 
ments of 500 kb) would be required for establishing a 
long-range restriction map spanning the entire chro- 
mosome 22. 
As a starting point for the physical map within the 
meningioma chromosomal region we chose the proto- 
oncogene PDGFB (22q12.3-13.1), which is the most 
proximal marker to be lost in meningioma with a 
(46,22q-) karyotype (Dumanski et al., 1987, 1990). 
Using a panel of somatic cell hybrids the marker 
D22S16 was localized to the same band region. Long- 
range restriction mapping is reported for both se- 
quences (D22S16 and PDGFB), placing both loci on a 
restriction fragment of 900 kb. Utilizing this mapping 
information we have studied possible rearrangements 
of PDGFB and D22S16 in meningioma. 
MATERIALS AND METHODS 
Cell Culture 
Meningioma tumor specimens and skin biopsies 
from the same patients were obtained freshly after 
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FIG. 1. (A) Multiplex reaction 1 with somatic cell hybrid 
DNAs as templates. Lane 1, CY14; 2, CY7; 3, CY125; 4, CY4; 6, 
CY2; 6, CY3; 7, A9 (mouse parent cell line used to generate most of 
the somatic cell hybrids); 8, human blood bank DNA. A mouse- 
derived PCR product is present in some reactions (lanes 1,6, and 
7); however, it can be readily distinguished from the STS PCR 
products and therefore does not interfere with the deletion analy- 
sis. The composition and sizes of multiplex 1 PCR products are 
given in Table 1. (B) Multiplex reactions 2 (lanes 1 to 7) and 3 
(lanes 8 to 14) with somatic cell hybrid DNAs as templates. Lanes 
1 and 8, human blood bank DNA; lane 2, CY14; lane 3, CY15; 
lanes 4 and 10, CY8; lanes 5 and 12, CY2; lanes 6 and 13, CY3; 
lanes 7 and 14, mouse A9 cell line; lane 9, CY12; lane 11, CY4; 
lane 16, HpaII-cut pUC19. The composition and sizes of multiplex 
2 and 3 PCR products are given in Table 1. Artifactual PCR prod- 
ucts of unknown origin are present in multipex 2 (- 140 bp) in 
lanes l-5 and primer dimer products are present in all reactions 
including mouse DNA controls. None of these bands interferes 
with the assignment of any locus. (C) Mapping NMORl using 
APRT (403) PCR product as positive control. Lane 1, CY18; lane 
2, CY6; lane 3, CY5. (D) Mapping CALBZ using HP PCR product 
as positive control. Lane 1, CY18; lane 2, CY5; lane 3, CY170. 
and Table 2). PCR products were electrophoresed in 
1.4% agarose gels and stained with ethidium bromide. 
Each of the multiplex reactions was optimized for 
Mg2+ concentration over the range of 3 to 9 mM 
MgCl, at 1.5 mA4 intervals (data not shown). The rela- 
tively high optimum Mg2+ concentrations for these 
reactions are due to the high nucleotide concentra- 
tions used (Kogan et al., 1987) which favor multiplex- 
ing (Chamberlain et ab, 1988). 
The somatic cell hybrid panel was derived using 
alanosine and adenine selection for APRT+ pheno- 
type on an uprt- A9 mouse cell line background (Cal- 
len, 1986). The human chromosomes were derived 
from cell lines containing various translocations or 
deletions of chromosome 16. The human APRT gene 
maps to the distal tip of the long arm of chromosome 
16 and all but one of the hybrids tested contain this 
locus. These hybrids therefore have breakpoints that 
map either on the short arm or proximal to the APRT 
locus on the long arm. The one hybrid that does not 
contain APRT is CY3, which was constructed by se- 
lection of the HPRT gene present on the X chromo- 
some, as the chromosome 16 material in this hybrid 
originated from an X;16 translocation (Callen, 1986). 
The PCR marker for the APRT gene was used as an 
internal positive control to verify negative results 
from the analysis of other loci. Two APRT PCR 
markers were designed utilizing the same forward 
primer but different reverse primers, and generated a 
200- or 403-bp PCR product (Table 1). This allowed 
for greater flexibility in the design of multiplex reac- 
tions (Table 2). Additional STSs were chosen from 
available DNA sequences of genes known to map to 
chromosome 16 and, where possible, from evenly 
spaced intervals over the length of the chromosome. 
In those cases where only cDNA sequence was avail- 
able, primer sequences were synthesized from the 3’ 
untranslated region in an attempt to avoid spanning 
introns. 
In all but one instance the size of the PCR product 
matched the published nucleotide sequence. The 
CR3A product was predicted to be 569 bp but was 
found to give a 490-bp product. This gene mapped to 
the 16pll-qll region, which is consistent with its 
previous localization (Corbi et cd., 1988). The se- 
quence between the two PCR primers at this locus 
contains about 200 bp which comprise mainly GT di- 
nucleotide repeats. Such repeats are frequently poly- 
morphic (Weber and May, 1989) and this may ac- 
TABLE 2 
Multiplex 
1 (locus) 2 (locus) 
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FIG. 2. (A, B) PFGE analysis of the marker D22S16 by double digest. Lymphocyte DNA was digested as indicated, separated by PFGE 
and probed with D22S16. The running conditions are given under Materials and Methods. (C) PFGE analysis of the gene PDGFB by double 
digest. The blot shown in Fig. 4B was hybridized with PDGFB. The hybridization with PDGFB yields fragments of similar size (as opposed 
to the size distribution obtained after hybridization with D22S16). (D) Large-scale map of the region flanking the sequence D22S16. The 
map is derived from the results summarized in Table 1. 
and 2B). Given the fact that the restriction sites for 
CM, NotI, and Sac11 are clustered and that the CZuI 
sites are situated outside the SfiI sites, the Not1 sites 
and the Sac11 sites should also fall outside the SfiI 
fragment. This extrapolation was verified by a @I/ 
Not1 and a SfiI/SacII double digest leaving the size of 
the SfiI fragment unaltered (Fig. 2B). Next to the 
Sac11 band at 200 kb an additional Sac11 band at 140 
kb was found. The Sac11 pattern remains unaltered 
even by an extended digestion with increased 
amounts of restriction enzyme, suggesting hyper- 
methylation of Sac11 sites. The smaller Sac11 frag- 
ment at 140 kb remains unaltered by subsequent di- 
gestion with Not1 or CM, indicating a Sac11 site 
within the 200-kb fragment that is flanked by the 
SocII/CluI/NotI cluster. The size of the NurI frag- 
ments appears to be unchanged by subsequent restric- 
tion with SfiI, placing the restriction sites for NurI 
between the SfiI fragment and the ClaI/NotI/SucII 
cluster. These results are summarized in the map 
shown in Fig. 2D. 
Large-Scale Restriction Mapping for PDGFB 
To map the PDGFB region we used the same rare 
cutting endonucleases as for the physical mapping of 
D22S16. In most cases, we obtained restriction frag- 
ments in the size range between 110 and 130 kb, sug- 
gestive of two clusters of CpG islands (Fig. 3). These 
findings are in good agreement with the localization 
of HTF islands (HpaII tiny fragments) upstream 
from the PDGFB gene (Gardiner-Garden and From- 
-. “--. .- -~ . -- 





FIG. 3. PFGE analysis of the gene PDGFB by single digest. 
DNA from two different lymphocyte samples was cleaved as indi- 
cated, separated by PFGE, and hybridized with PDGFB. The run- 
ning conditions are given under Materials and Methods. 




FIG. 4. Variations of the Not1 restriction pattern identified by 
PFGE. Lymphocyte DNA from three individuals was digested with 
NotI, separated by PFGE, and hybridized with PDGFB. The run- 
ning conditions are given under Materials and Methods. Next to 
the 130-kb band an additional signal at 450 kb can be demon- 
strated in two lymphocyte samples. 
mer, 1987). HTF islands contain a high frequency of 
unmethylated CpG dinucleotides and, therefore, a 
higher density of restriction sites for rare cutting en- 
zymes. These results were confirmed by a combina- 
tion of double digests: The fragment sizes obtained in 
a single restriction are not significantly reduced by 
subsequent restriction with a second enzyme, placing 
the recognition sites for the used enzymes close to 
each other (Fig. 2C). 
To ensure that both enzymes were active in the dou- 
ble digest each experiment was accompanied by two 
single digests using the enzymes separately. In addi- 
tion, all blots were hybridized with both probes. A 
representative blot is shown in Figs. 2B and 2C. Fol- 
lowing hybridization with PDGFB the probe was re- 
moved, and the blot was rehybridized with the 
D22S16 probe. As demonstrated in Fig. 2C, PDGFB 
fragments of similar size have been found in the single 
Not1 and SfiI digests and in the NotI/SfiI double di- 
gests. Following rehybridization with D22S16, the 
size of the Not1 fragment (200 kb) was reduced to 50 
kb in a NotI/SfiI double digest. A band of 50 kb was 
also found following the single SfiI digest (Fig. 4B). 
Finally, a variation of the Not1 restriction pattern 
has been found between different individuals. As dem- 
onstrated in Fig. 4, next to the 130-kb band, we found 
an additional 450-kb signal in some lymphocyte sam- 
ples. While the 130-kb band was observed in all indi- 
viduals, the additional band was only found in 7 of 11 
individuals. In none of the tested samples did we de- 
tect a single 450-kb band. 
Variation of the Not1 restriction pattern has al- 
ready been described for other probes such as pmetH 
in which case the variation is due to a site polymor- 
phism (Julier and White, 1988; Collins et al., 1987). It 
remains to be shown whether the PDGFB variation 
reflects a point mutation, a major rearrangement, or a 
difference in the methylation pattern. 
Physical Linkage of PDGFB and D22Sl6 
To physically link the gene PDGFB and the marker 
D22S16, we used extended pulsed times and condi- 
tions for partial restriction digestion (Fig. 5). Restric- 
tion fragments containing the two loci were identified 
by sequential hybridization to both probes. The re- 
striction endonucleases NotI, SfiI, and ClaI did not 
produce DNA fragments long enough to be recognized 
by the two probes. However, the enzyme NruI re- 
vealed two fragments (900 and 1300 kb) that hybrid- 
ize to D22S16 and PDGFB, thereby, indicating the 
maximum distance for these two markers (Fig. 5). 
Linkage was also found using the enzyme MuI, con- 
firming the results obtained by NruI digest. Smaller 
NruI fragments that were unique to each probe in- 
units Nrul/Fg 
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FIG. 5. Physical linkage of the marker D22S16 and the gene 
PDGFB. The DNA was restricted by increasing concentrations of 
NruI and separated by PFGE. The running conditions were as 
follows: The pulse time was gradually increased from 30 to 60 min 
for 144 h, followed by a second ramp from 10 tn 30 min for 22 h. 
Following transfer, the membrane was hybridized to PDGFB, the 
probe was removed, and the blot was reprobed with D22S16. The 
two bands (900 and 1300 kb) migrated a slightly reduced distance 
when more fragments were generated by increasing enzyme con- 
centrations. 





Tl T2 Ll L2 L3 Fl F2 
kb 
PFGE analysis of meningioma DNA using D22S16 and 
PDGFB. (A) The indicated samples (Tl, TS-meningioma DNA; 
Ll, L2, LB-lymphocyte DNA, Fl, F2-fihrohlast DNA) were di- 
gested by NotI, separated by PFGE, and probed with PDGFB. The 
running conditions are given under Materials and Methods. (B) 
Following hybridization with PDGFB, the blot shown in A was 
stripped and rehybridized with D22S16. 
elude a 400-kb fragment for D22S16 and a fragment 
at 500 kb for PDGFB (data not shown). 
PFGE Analysis of Meningiomm 
The flanking regions of PDGFB and D22S16 have 
been analyzed in cell cultures from six meningiomas. 
Following restriction with NotI, PDGFB fragments of 
identical sizes have been identified in meningioma 
and fibroblasts (Fig. 6), as well as in dura mater and 
arachnoid DNA (data not shown). Arachnoid cells are 
considered to be the cells of origin for meningioma. 
Lymphocyte DNA reveals a slightly different methyl- 
ation status. Following hybridization with D22S16, 
an identical pattern was demonstrated in all analyzed 
cell types. Two additional enzymes (ClaI and SacII) 
also failed to demonstrate specific alterations in me- 
ningiomas. 
DISCUSSION 
The migration of DNA molecules in PFGE gels de- 
pends on a number of variables (e.g., switching time, 
voltage gradient, DNA concentration, etc.) and can 
easily be modified by even small variations of one of 
the parameters (Birren et al., 1988). For example, the 
occurrence of a peak in the size distribution of restric- 
tion fragments may result in altered migration due to 
local overloading of the gel. Therefore, we included 
several controls for each experiment. First, all experi- 
ments were repeated three times with DNA from dif- 
ferent individuals. Second, as mentioned above, in 
cases where the fragment size remained unaltered by 
subsequent digest with another enzyme, we rehybri- 
dized with a second unrelated probe. Finally, the 
order of the restriction enzymes used in the double 
digest was reversed (e.g., the results of a CZ.oI/SacII 
digest were verified by a SucII/CZuI restriction). 
As a starting point for the large scale restriction 
map of chromosome 22, we have chosen the proto-on- 
cogene PDGFB. Surprisingly, relatively small frag- 
ments have been identified even for enzymes (e.g., 
Not1 that usually generate significantly larger frag- 
ments (Barlow and Lehrach, 1987)). Using a combina- 
tion of single and double digests we identified two 
CpG clusters flanking the PDGFB gene. Using the 
GeneBank sequence data, Gardiner-Garden and 
Frommer (1987) analyzed the distribution of HTF is- 
lands with respect to gene termini. They identified 
CpG islands predominantly at the 5’ end of many ana- 
lyzed genes including PDGFB. In a few instances 
both 5’ and 3’ CpG islands were found. Our results 
support the notion that an HTF island is present 3’ to 
the PDGFB gene. However, the possibility cannot yet 
be excluded that this HTF island may represent a 5’ 
CpG cluster related to an as yet unidentified tran- 
scription unit bordering the 3’ end of the PDGFB 
gene. 
We report here the extension of the physical map 
surrounding the PDGFB gene. The marker D22S16 
was sublocalized to the band region 22q13.1 utilizing a 
hybrid mapping panel. By means of PFGE D22S16 
was shown to be situated within 900 kb of the PDGFB 
gene. In addition, we studied meningiomas using 
these two probes in PFGE experiments. Neither 
PDGFB nor D22S16 detected any structural rear- 
rangement in meningioma. 
Our results should assist in localizing the region of 
the putative suppressor gene in meningioma. To- 
gether with the recently published physical map of 
the band region 22qll (McDermid et aZ., 1989), 
our data for the region 22q12.3-13.1 contribute to 
the development of a complete physical map of chro- 
mosome 22. 
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